Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Systemic dosing only; not an otic or ophthalmic product protocol.
Check source scope before reading a dose
GlobalRPh RX List - FLOXIN
Product / population
Systemic oral ofloxacin, not otic or ophthalmic products. Historical infection indications require current treatment-policy review.
Renal method
Steady-state Cockcroft-Gault CrCl using actual body weight in the printed formula, mL/min.
Source revision
Source revision date not established in selected retrieval.
Retrieved
2026-09-07
Local review status
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Documented differences and cautions on this drug
All record notes are retained here, including notes about sources not selected in this review.
Introduction and table differ at exactly CrCl 50
The introductory adjustment trigger is <50, but the first table band includes 20-50. The dose unit remains indication-specific.
What to reconcile: Resolve exactly 50 against the applicable current product and institutional policy instead of silently assigning it.
GlobalRPh-hosted RX List · Systemic oral ofloxacin, not otic or ophthalmic products. Historical infection indications require current treatment-policy review.
Renal method: Steady-state Cockcroft-Gault CrCl using actual body weight in the printed formula, mL/min. Source date: Source revision date not established in selected retrieval. Retrieved: 2026-09-07
Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Renal dosing, restrictions and evidence limits
After the usual initial dose, the renal table specifies: CrCl 20-50 mL/min, usual indication-specific unit dose every 24 hours; CrCl <20, one-half of that unit dose every 24 hours. The introductory text says adjustment below 50 but the table includes 50. Resolve that exact boundary before use; do not silently round into a band. A unit dose depends on indication.
RDM41-rxlist-ofloxacin-25a2a9538f-C1 · Source locator: Dosage / Use in specific populations: renal impairment
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.